XOMA Royalty Corp. (XOMA)
26.37
+0.84
(+3.29%)
USD |
NASDAQ |
Mar 02, 16:00
26.37
0.00 (0.00%)
After-Hours: 17:15
XOMA Royalty Enterprise Value : 376.12M for Feb. 27, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Mirum Pharmaceuticals, Inc. | 4.679B |
| Recursion Pharmaceuticals, Inc. | 1.240B |
| Rezolute, Inc. | 175.54M |
| DiaMedica Therapeutics, Inc. | 358.96M |
| Gossamer Bio, Inc. | 121.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 10.35M |
| Revenue (Quarterly) | 9.351M |
| Total Expenses (Quarterly) | -0.998M |
| EPS Diluted (Quarterly) | 0.6991 |
| Gross Profit Margin (Quarterly) | 90.59% |
| Earnings Yield | 2.83% |
| Normalized Earnings Yield | -2.411 |